Merge Labs – Altman-Backed BCI Lab Using Biomolecular Ultrasound (merge.io)

Merge Labs has announced its ambitious mission to bridge biological intelligence and artificial intelligence through revolutionary brain-computer interfaces (BCIs) designed to enhance human abilities and experiences. The lab aims to develop high-bandwidth, safe, and accessible BCIs that utilize novel technologies for neuron interaction, moving beyond traditional electrodes to molecular connections and non-invasive methods like ultrasound. This approach could lead to significant advancements in restoring lost abilities, improving mental health, and enhancing human creativity in collaboration with AI. The significance of Merge Labs' initiative lies in its potential to drastically improve BCI technology, allowing for increased data exchange with the brain while minimizing invasiveness. Recent advancements in biotechnology and neuroscience provide a foundation for this endeavor, but the team acknowledges that achieving its long-term vision will require interdisciplinary collaboration and a decade-long commitment. By prioritizing safety, privacy, and accessibility, Merge Labs not only seeks to create effective solutions for patients with injuries or diseases but also to advance the overall human experience in the age of AI. Their commitment to transparency and collaboration with the broader community further underscores their goal of democratizing access to these transformative technologies.